Skip to main content
. 2020 Dec 21;10(1):e018777. doi: 10.1161/JAHA.120.018777

Table 3.

T2* Values at Baseline and With MH in Control and CHD Subjects. Values Listed by CHD Subgroup as Well

Control

N=20

CHD

N=24

LSOL

N=15

RSOL

N=2

TGA

N=7

P Value +

GA scan, wks

Mean, SD

33.9

(33.6, 34.4)

33.8

(33.4, 34.2)

33.6

(33.2, 34.1)

34.1

(32.1, 36.2)

34.2

(33.5, 34.9)

0.64

EFW, g

Mean, SD

2268.8

(2150.7, 2386.8)

2283.7

(2144.1, 2423.4)

2161.7 (2020.5, 2302.9) 2324.5 (1860.7, 2788.3) 2534.7 (2257.6, 2811.6) 0.86

TBV, mL

Mean, SD

262.4

(245.0, 279.8)

238.2

(224.6, 251.9)

235.1

(215.2, 252.7)

256.3

(215.2, 252.7)

241.6

(214.7, 259.3)

0.04

T2* base, ms

Mean, 95% CI

99.7

(93.0, 106.4)

84.8

(78.9, 90.7)

84.5

(77.4, 91.6)

81.6

(65.0, 98.2)

86.3

(70.6, 102.0)

0.002

T2* MH, ms

Mean, 95% CI

99.5

(94.1, 104.8)

88.9 §

(81.4, 96.5)

87.4

(77.3, 97.5)

84.8

(84.7, 85.0)

93.6 §

(79.9, 107.2)

0.06

T2* change, ms

Mean, 95% CI

−0.2

(−7.3, 6.8)

4.2

(0.5, 7.8)

2.9

(−2.4, 8.1)

3.2

(−13.2, 19.7)

7.2

(4.6, 9.8)

0.1

CHD indicates congenital heart disease; EFW, estimated fetal weight; GA, gestational age; LSOL, left‐sided obstructive lesion; MH, maternal hyperoxia; RSOL, right‐sided obstructive lesion; TBV, total brain volume; and TGA, transposition of the great arteries.

+

P value represents comparison between control and CHD group using linear regression with adjustment for gestational age at scan and fetal sex.

P value represents comparison between control group and each subtype of congenital heart disease using a linear regression model with adjustment for gestational age at scan. Those with the symbol are significantly different from the control group (P<0.05).

§

Paired t test within each group, symbol denotes significant change of T2* from baseline to MH (P<0.05).